Biotech

All Articles

Metsera join Amneal to secure down GLP-1 source

.With early stage 1 records right now out in the wild, metabolic health condition ensemble Metsera i...

Rivus blog posts information to support muscle-sparing excessive weight drug cases

.Rivus Pharmaceuticals has introduced the information behind its phase 2 weight problems gain in hea...

BMS spends $110M to create T-cell treatment contract, helping Best purchase opportunity to advance prioritized pipe

.Bristol Myers Squibb is actually paying out Perfect Medicine $110 thousand in advance to create rea...

Generate increases one more $1B-plus Large Pharma alliance

.Novartis has actually printer inked a package potentially worth greater than $1 billion with Flagsh...

Metsera GLP-1 information cut shows 7.5% fat loss at 36 times

.Recently debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist...

Flagship wishes biotechs flock to Mirai to enhance hereditary medications

.In the middle of the genetic medications branches nationality, Flagship Pioneering is actually unve...

BioAge eyes $180M coming from IPO, private placement for being overweight trials

.BioAge Labs is actually checking out all around $180 million in initial earnings from an IPO and a ...

Merck's LAG-3 combination stops working colorectal cancer phase 3 research

.An effort by Merck &amp Co. to unlock the microsatellite secure (MSS) metastatic colon cancer marke...

Spanish VC closes $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has actually finalized a fund of 180 million europeans ($ 200 thousand)...

BioAge brings in $198M from IPO as obesity biotech signs up with Nasdaq

.BioAge Labs is generating practically $200 million using its own Nasdaq IPO today, along with the e...